Cebranopadol for acute pain after surgery or injury
Part of Pain clinical trials.
This study tests an investigational medication called cebranopadol to see if it safely and effectively relieves acute (short-term) pain after surgery or from a muscle or bone injury. It may offer a new option for people who need relief from moderate to severe pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have moderate to severe pain from a recent outpatient surgery (expected to last at least 72 hours) or from a muscle or bone injury.
- Your pain score is at least 4 on a 0 to 10 scale before starting the study treatment.
- You are not currently taking daily pain medication for a chronic pain condition.
- You do not have a history of substance abuse (drugs or alcohol) and are not allergic to the study drug or rescue pain medications.
- You are not pregnant or breastfeeding and agree to follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, cebranopadol, to help reduce withdrawal symptoms when people with chronic pain stop or reduce their opioid painkillers. It may help make the withdrawal process more comfortable and manageable.
This trial tests if a new medicine, CBP-0276, can help reduce the amount of opioids needed for pain after major bone surgery. It may help manage pain with fewer side effects.
This study tests a new pain medicine called Combogesic for teenagers aged 12 to 17 who have moderate to severe pain after orthopedic surgery (surgery on bones, joints, or muscles). The medicine combines two common pain relievers to see if it works better and is safe for teens.
This trial tests an investigational tablet called HL-1186 for controlling pain after orthopedic surgery. It explores whether the drug can safely reduce moderate to severe pain when given after the procedure.
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
This study tests an experimental pain reliever (KHN702) for people who have moderate to severe pain after surgery. If you are scheduled for an operation, this trial aims to find out if this medication can safely reduce your post-operative pain.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.